The effect of micronutrient supplementation on active TB incidence early in HIV infection in Botswana

References

• World Health Organization. Global Tuberculosis Report. Available from: http://www.who.int/tb/publications/global_report/gtbr2016_executive_summary.pdf?ua=1. Accessed May 2, 2017.
   Google Scholar
• World Health Organization. Tuberculosis (TB). TB and HIV. Available from: http://www.who.int/tb/areas-of-work/tb-hiv/en/. Accessed May 2, 2017.
   Google Scholar
• World Health Organization. HIV-Associate Tuberculosis. Fact sheet. http://www.who.int/tb/areas-of-work/tb-hiv/tbhiv_factsheet_2016_web.pdf?ua=1. Accessed May 2, 2017.
   Google Scholar
• Barry CE, Boshoff HI, Dartois V, Dick T, Ehrt S, Flynn J, et al. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol. 2009;7(12):845–855.
   PubMed Web of Science ®Google Scholar
• Harries AD, Dye C. Tuberculosis. Ann Tropical Med Parasitol. 2006;100(5–6):415–431.
   PubMed Web of Science ®Google Scholar
• WHO. HIV/AIDS. Tuberculosis and HIV. Available from: http://www.who.int/hiv/topics/tb/about_tb/en/. Accessed May 2, 2017.
   Google Scholar
• World Health Organization. Interim Policy on Collaborative TB/HIV Activities; WHO/HTM/TB/2004.330 WHO/HTM/HIV/2004.1. Available from: http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.384.7644. Accessed June 14, 2017.
   Google Scholar
• UNAIDS. Getting to zero. 2011–2015 strategy. Geneva, Joint United Nations Programme on HIV/AIDS. Available from http://www.unodc.org/documents/southeastasiaandpacific/Publications/2011/JC2034_UNAIDS_Strategy_en.pdf. Accessed June 14, 2017.
   Google Scholar
• World Health Organization. Botswana Tuberculosis profile. Available from: https://extranet.who.int/sree/Reports?op=Replet&name=%2FWHO_HQ_Reports%2FG2%2FPROD%2FEXT%2FTBCountryProfile&ISO2=BW&outtype=html. Accessed June 12, 2012.
   Google Scholar
• Wester W, Bussman H, Avalos A, et al. Establishment of public antiretroviral treatment clinic for adults in urban Botswana: Lessons learned. Clin Iinfect Dis. 2005:40(7):1041–1044.
   PubMed Web of Science ®Google Scholar
• Bussmann H, Wester CW, Thomas A, et al. Response to zidovudine/didanosine-containing combination antiretroviral therapy among HIV-1 subtype C-infected adults in Botswana: two-year outcomes from a randomized clinical trial. J Acquir Immune Defic Syndr. 2009;51(1):37–46.
   Web of Science ®Google Scholar
• Sibanda T, Tedla Z, Nyirenda S, et al. Anti-tuberculosis treatment outcomes in HIV-infected adults exposed to isoniazid preventive therapy in Botswana. Int J Tuberc Lung Dis. 2013;17(2):178–185.
   Web of Science ®Google Scholar
• Sinclair D, Abba K, Grobler L, Sudarsanam TD. Nutritional supplements for people being treated for active tuberculosis. Cochrane Database Syst Rev. 2011;(11):CD006086.
   Google Scholar
• Ramakrishnan K, Shenbagarathai R, Kavitha K, Thirumalaikolundusubramanian P, Rathinasabapati R. Selenium levels in persons with HIV/tuberculosis in India, Madurai City. Clin Lab. 2012;58(1–2):165–168.
   PubMed Web of Science ®Google Scholar
• Isanaka S, Aboud S, Mugusi F, et al. Iron status predicts treatment failure and mortality in tuberculosis patients: a prospective cohort study from Dar es Salaam, Tanzania. PLoS One. 2012;7(5):e37350.
   PubMed Web of Science ®Google Scholar
• Afridi HI, Kazi TG, Kazi N, et al. Evaluation of zinc, copper and iron in biological samples (scalp hair, blood and urine) of tuberculosis and diarrhea male human immunodeficiency virus patients. Clin Lab. 2011;57(9–10):677–688.
   Web of Science ®Google Scholar
• Plit ML, Theron AJ, Fickl H, van Rensburg CE, Pendel S, Anderson R. Influence of antimicrobial chemotherapy and smoking status on the plasma concentrations of vitamin C, vitamin E, beta-carotene, acute phase reactants, iron and lipid peroxides in patients with pulmonary tuberculosis. Int J Tuberc Lung Dis. 1998;2(7):590–596.
   Web of Science ®Google Scholar
• Nnoaham KE, Clarke A. Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int J Epidemiol. 2008;37(1):113–119.
   PubMed Web of Science ®Google Scholar
• Louw JA, Werbeck A, Louw MEJ, Kotze TJvW, Cooper R, Labadarios D. Blood vitamin concentrations during the acute phase response. Crit Care Med. 1992;20(7):934–941.
   PubMed Web of Science ®Google Scholar
• Mehta S, Mugusi FM, Bosch RJ, et al. A randomized trial of multivitamin supplementation in children with tuberculosis in Tanzania. Nutr J. 2011;10:120.
   PubMed Web of Science ®Google Scholar
• Range N, Changalucha J, Krarup H, Magnussen P, Andersen AB, Friis H. The effect of multi-vitamin/mineral supplementation on mortality during treatment of pulmonary tuberculosis: a randomised two-by-two factorial trial in Mwanza, Tanzania. Br J Nutr. 2006;95(4):762–770.
   PubMed Web of Science ®Google Scholar
• Villamor E, Mugusi F, Urassa W, et al. A trial of the effect of micronutrient supplementation on treatment outcome, T cell counts, morbidity, and mortality in adults with pulmonary tuberculosis. J Infect Dis. 2008;197(11):1499–1505.
   PubMed Web of Science ®Google Scholar
• Baum MK, Campa A, Lai S, et al. Effect of micronutrient supplementation on disease progression in asymptomatic, antiretroviral-naïve, HIV-infected adults in Botswana. JAMA. 2013;310(20):2154–2163.
   PubMed Web of Science ®Google Scholar
• Goggins WB, Finkelstein DM, Schoenfeld DA, Zaslavsky AM. A Markov chain Monte Carlo EM algorithm for analyzing interval-censored data under the Cox proportional hazards model. Biometrics. 1998;54(4):1498–1507.
   Web of Science ®Google Scholar
• McAllister FA, Straus SE, Sackett DL, Altman DG. Analysis and reporting of factorial trials: systematic review. JAMA. 2003, 289(19):2545–2553.
   Web of Science ®Google Scholar
• Gaugler T, Akritas MG. Testing for interaction in two-way random and mixed effects models: the fully nonparametric approach. Biometrics. 2011;67(4):1314–1320.
   Web of Science ®Google Scholar
• Hughes MD, Pocock SJ. Interim monitoring of clinical trials. In: Finkelstein DM, Schoenfeld DA, editors. AIDS Clinical Trials. Hoboken, NJ: Wiley & Sons; 1995:177–196.
   Google Scholar
• Samandari T, Agizew TB, Nyirenda S, et al. 6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial. Lancet. 2011;377(9777):1588–1598.
   PubMed Web of Science ®Google Scholar
• Campa A, Baum MK. Micronutrients and HIV-Infection. HIV Therapy. 2010;4(4):437–469.
   Google Scholar
• Cegielski JP, McMurray DN. The relationship between malnutrition and tuberculosis: evidence from studies in humans and experimental animals. Int J Tuberc Lung Dis. 2004;8(3):286–298.
   PubMed Web of Science ®Google Scholar
• World Health Organization.2015. TB/HIV facts 2015. Available from: http://www.who.int/hiv/topics/tb/tbhiv_facts_2015/en/. Accessed May 3, 2017.
   Google Scholar
• Gopi A, Madhavan SM, Sharma SK, Sahn SA. Diagnosis and treatment of tuberculous pleural effusion in 2006. Chest. 2007;131(3):880–889.
   PubMed Web of Science ®Google Scholar
• Semba RD, Kumwenda J, Zijlstra E, et al. Micronutrient supplements and mortality of HIV-infected adults with pulmonary TB: a controlled clinical trial. Int J Tuberc Lung Dis. 2007;11(8):854–859.
   PubMed Web of Science ®Google Scholar
• Beisel WR. AIDS. Chapter 32. In: Gershwin ME, German JB, Keen CL, editors. Nutrition and Immunology: Principles and Practices. Totowa, NJ: Humana Press; 2000:389–403.
   Google Scholar
• Taylor EW, Nadimpalli RG, Ramanathan CS. Genomic structure of viral agents in relation to the biosynthesis of seleno proteins. In: Scharauzer GN, Montagnier L, editors. Proceedings of the First International Symposium on “Human Viral Diseases: Selenium, Antioxidants and other Emerging Strategies of Therapy and Prevention,” April 1996, Nonwiler, Germany: Biol Trace Elem Res; 1997;56:63–91.
   Google Scholar
• Ndeezi G, Tylleskär T, Ndugwa CM, Tumwine JK. Effect of multiple micronutrient supplementation on survival of HIV-infected children in Uganda: a randomized, controlled trial. J Int AIDS Soc. 2010;13:18.
   PubMed Web of Science ®Google Scholar
• Ndeezi G, Tumwine JK, Ndugwa CM, Bolann BJ, Tylleskär T. Multiple micronutrient supplementation improves vitamin B12 and folate concentrations of HIV infected children in Uganda: a randomized controlled trial. Nutr J. 2011;10:56.
   PubMed Web of Science ®Google Scholar
• Macallan DC. Malnutrition in tuberculosis. Diagn Microbiol Infect Dis. 1999;34(2):153–157.
   PubMed Web of Science ®Google Scholar
• Kotler DP. Nutritional alterations associated with HIV infection. J Acquir Immune Defic Syndr. 2000;25(Suppl 1):S81–S87.
   Google Scholar
• Chandra RK. Nutrient supplementation as adjunct therapy in pulmonary tuberculosis. Int J Vitam Nutr Res. 2004;74(2):144–146.
   Web of Science ®Google Scholar
• Zachariah R, Spielmann MP, Harries AD, Salaniponi FM. Moderate to severe malnutrition in patients with tuberculosis is a risk factor associated with early death. Trans R Soc Trop Med Hyg. 2002;96(3):291–294.
   PubMed Web of Science ®Google Scholar
• Tang AM, Graham NM, Saah AJ. Effects of micronutrient intake on survival in human immunodeficiency virus type 1 infection. Am J Epidemiol. 1996;143(12):1244–1256.
   PubMed Web of Science ®Google Scholar
• Baum MK, Shor-Posner G, Lai S, et al. High risk of HIV-related mortality is associated with selenium deficiency. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;15(5):370–374.
   PubMedGoogle Scholar
• Baum MK, Shor-Posner G. Micronutrient status in relationship to mortality in HIV-1 disease. Nutr Rev. 1998;56(1 Pt 2):S135–S139.
   Web of Science ®Google Scholar
• De Maayer T, Saloojee H. Clinical outcomes of severe malnutrition in a high tuberculosis and HIV setting. Arch Dis Child. 2011;96(6):560–564.
   PubMed Web of Science ®Google Scholar
• Briggs MA, Emerson C, Modi S, Taylor NK, Date A. Use of isoniazid preventive therapy for tuberculosis prophylaxis among people living with HIV/AIDS: a review of the literature. J Acquir Immune Defic Syndr. 2015;68(Suppl 3):S297–S305.
   PubMedGoogle Scholar
• Smith T, Samandari T, Abimbola T, Marston B, Sangrujee N. Implementation and operational research: cost-effectiveness of antiretroviral therapy and isoniazid prophylaxis to reduce tuberculosis and death in people living with HIV in Botswana. J Acquir Immune Defic Syndr. 2015;70(3):e84–e93.
   Web of Science ®Google Scholar